Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
Date:11/5/2012

nine months ended September 30, 2012, cost of product sales was 49% of net product revenue, compared to 64% for the comparable period in 2011. This decrease includes efficiencies achieved in 2012 as a result of higher production volumes, which were partially offset by higher freight costs resulting from the company's temporary supply disruption during the first quarter of this year, unabsorbed manufacturing costs, and an inventory write-down. These excess costs were primarily related to Cadence's previously reported suspension of production of OFIRMEV at its initial contract manufacturer's facility.

Research and development expenses for the three months ended September 30, 2012, increased $0.5 million to $2.2 million, from $1.7 million for the comparable period in 2011. This increase was primarily a result of severance obligations related to the departure of two of the company's officers, and included approximately $0.3 million of non-cash, stock-based compensation expense. For the nine months ended September 30, 2012, the company reported research and development expenses of $5.4 million, a decrease of $1.6 million from the $7.0 million reported for the comparable period in 2011. This reduction was primarily attributable to the workforce restructuring implemented in the fourth quarter of 2011, partially offset by severance charges incurred during the third quarter of 2012.

Selling, general and administrative costs for the three months ended September 30, 2012, increased $0.1 million to $20.0 million, from $19.9 million for the three months ended September 30, 2011. For the nine months ended September 30, 2012, selling, general and administrative expenses increased $5.8 million to $66.8 million, from $61.0 million for the comparable period in 2011. This increase was mostly attributable to legal costs incurred in relation to the company's ongoing intellectual property litigation, and increased commissions earned by Cadence's hospital sales specialists
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
2. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2012 Financial Results On August 2, 2012
3. Cadence Pharmaceuticals To Present At The Wedbush PACGROW Life Sciences Management Access Conference In New York City On August 14, 2012
4. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2012 In Boston On September 5, 2012
5. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2012 Financial Results On November 5, 2012
6. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Research and Markets  has announced the ... Product, End-user & by Lead Type - Global Forecast ... http://photos.prnewswire.com/prnh/20130307/600769 The global ... segments, namely, holter monitor, resting, and stress type diagnostic ... million in 2013 and is poised to grow at ...
(Date:7/23/2014)... -- RT Oncology Services Corporation today announced that Craig ... directors. Mr. Mundie is currently senior advisor to the ... projects within the company and on technology strategy and ... officer. Mike Martin , president ... a visionary technology executive. His appointment is part of ...
(Date:7/23/2014)... July 23, 2014  Nonin Medical, Inc., the inventor ... medical monitoring, announced today that Mark VanderWerf , ... elected Chairman of the American Telemedicine Association,s (ATA) Industry ... The ATA is the leading international resource ... technologies. The ATA and its diverse membership work to ...
Breaking Medicine Technology:Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 2Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 3Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3Nonin Medical Announces that Mark VanderWerf has been Elected Chairman of the American Telemedicine Association's Industry Council 2
... Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: ... on developing topically administered products using its proprietary transdermal ... exploring strategic alternatives aimed at enhancing shareholder value with ... Advisors, a division of KEMA Partners.  The goal ...
... 31, 2011 Nephros, Inc. (OTC Bulletin Board: ... marketing filtration products for therapeutic applications, infection control, and ... Form S-1 for its previously announced rights offering to ... 2011 by the Securities and Exchange Commission. ...
Cached Medicine Technology:Transdel Pharmaceuticals Announces Exploration of Strategic Alternatives 2Transdel Pharmaceuticals Announces Exploration of Strategic Alternatives 3Nephros Rights Offering Registration Statement Declared Effective 2Nephros Rights Offering Registration Statement Declared Effective 3Nephros Rights Offering Registration Statement Declared Effective 4
(Date:7/23/2014)... been focused on the regions of the coding genome ... of amino acids thus proteins. But just before each ... controls the expression and activity of the adjacent gene. ... exerted such DNA fragment in tumor development. , ... collaboration with the group of Manel Esteller, Director of ...
(Date:7/23/2014)... Ticket Down is a reputable ... at Michigan Stadium . One of the most anticipated ... held at the Big House in Ann Arbor. Michigan Stadium, ... home to a game between Manchester United from the English ... will be held on August 2nd and could be the ...
(Date:7/23/2014)... 2014 A therapy combining salmon fibrin injections into ... into the brain restored voluntary motor function impaired by ... Center have found. , In a study on rodents, ... turning back the developmental clock in a molecular pathway ... and providing a scaffold so that neuronal axons at ...
(Date:7/23/2014)... July 23, 2014 Ticket Down ... Roma tickets in Dallas, TX at the Cotton Bowl. ... tournament held in the United States and Canada beginning on ... including teams from La Liga, Serie A, English Premier League, ... Manchester United, Manchester City, Olympiacos, Inter Milan, Liverpool, AS Roma, ...
(Date:7/23/2014)... This report defines and segments the "EHV Transmission Market ... & Africa, and Americas) - Global Trends & Forecasts ... forecasts of the global revenue. The global EHV transmission ... in 2014 to nearly $14 billion by 2019 at ... Market Tables and 10 Figures Spread Through 220 Pages ...
Breaking Medicine News(10 mins):Health News:Real Madrid vs. Manchester United Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for ManU vs. Real Madrid Guinness International Champions Cup Tickets 2Health News:Real Madrid vs. Manchester United Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for ManU vs. Real Madrid Guinness International Champions Cup Tickets 3Health News:Gene inhibitor, salmon fibrin restore function lost in spinal cord injury 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 2Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 3Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 4
... ... and Research (CDER) will soon initiate a major enforcement initiative against cosmetics product ... L. England, former 17-year FDA veteran and FDAImports.com, LLC Founder. ... (Vocus) ...
... A ... Officers Association as the 2010 Health Leader of the Year. This is a distinction ... the health of the American people and that of the larger global community. ... San Diego, CA (PRWEB) May ...
... ... It,s 501(c)(3) application is filed, it has a bank account, and it even has ... What it needs now is a logo, and it has launched a nationwide ... The Spice House, singer Gretchen Wilson, and writer Michael Z. Williamson. , ...
... PITTSBURGH, May 23 Young women of reproductive-age are among ... have suggested that during pregnancy women are even more susceptible ... a time when men also are at greater risk. In ... and pregnant. The results were presented today at ...
... ... Moschetti’s collection , ... (Vocus) May 23, 2010 -- Readers will be struck by the illuminative work of a ... of the Prisoner. True to its name, this reflective anthology reveals the profound emotions and ...
... KitPackers®, ... This agreement provides the 3MTM Industrial Adhesives and Tapes Division with custom modification and ... such as epoxies, acrylics, urethanes, and premixed and frozen. , ... Germantown, WI (PRWEB) May 23, ...
Cached Medicine News:Health News:FDA to Take Up Major Enforcement Action Against Cosmetics Manufacturers With Illegal “Anti-Aging” Labeling Claims, According to FDAImports.com, LLC 2Health News:FDA to Take Up Major Enforcement Action Against Cosmetics Manufacturers With Illegal “Anti-Aging” Labeling Claims, According to FDAImports.com, LLC 3Health News:FDA to Take Up Major Enforcement Action Against Cosmetics Manufacturers With Illegal “Anti-Aging” Labeling Claims, According to FDAImports.com, LLC 4Health News:Health Leader of the Year for 2010 - U.S. Senator Daniel K. Inouye 2Health News:Health Leader of the Year for 2010 - U.S. Senator Daniel K. Inouye 3Health News:Health Leader of the Year for 2010 - U.S. Senator Daniel K. Inouye 4Health News:Art Contest for New Charity With A History 2Health News:Art Contest for New Charity With A History 3Health News:Art Contest for New Charity With A History 4Health News:Pregnancy doubles HIV risk in men; first trial of a microbicide in pregnant women 2Health News:Pregnancy doubles HIV risk in men; first trial of a microbicide in pregnant women 3Health News:Pregnancy doubles HIV risk in men; first trial of a microbicide in pregnant women 4Health News:The Heart of the Prisoner Revealed 2Health News:KitPackers Offers 3MTM Repackaging Capability 2
... manufacturers focus attention on implant design, one ... Profix Total Knee System seeks to establish ... system and the tools to implant them. ... recognized for innovation in total knee instrumentation, ...
The RT-PLUS Solution is an axially supported rotation knee prosthesis for cemented implantation. The implant is available in three sizes, each of which can be combined with the next size up or down....
Cementless hip system...
... knee system was designed to ... between all articulating surfaces and ... with wear in order to ... with normalized quadriceps and patellar ...
Medicine Products: